having me german biotech specialist biotech is buying a production facility in the german city of marburg from pharma giant novartis many analysts consider buying a leading contender in the race to produce a coven 1000 back seen at a press conference the company says it's working on a vaccine using messenger r.n.a. the drug is being developed in cooperation with pfizer and is currently in late stage testing pfizer has called the test successful so far with patients experiencing only minor side effects production of a vaccine is scheduled to begin in the 1st half of next year at an annual capacity of $750000000.00 doses the firm has contracts with governments around the world to supply the drug. our financial correspondent chelsea delaney has more. well beyond tech is certainly one of the farthest along in terms of developing a crown of virus vaccine what they have said is that they do expect to submit data to the f.d.a. the u.s. regulator by the end of october along with their partner pfizer that means that it could potentially be approved by october or november and is shipped out soon af

having me german biotech specialist biotech is buying a production facility in the german city of marburg from pharma giant novartis many analysts consider buying tech a leading contender in the race to produce a covert 1000 back seen at a press conference the company says it's working on a vaccine using messenger r.n.a. the drug is being developed in cooperation with pfizer and is currently in late stage testing pfizer has called the test successful so far with patients experiencing only minor side effects production of a vaccine is scheduled to begin in the 1st half of next year at an annual capacity of $750000000.00 doses the firm has contracts with governments around the world to supply the drug. our financial correspondent chelsea delaney has more. well beyond texas certainly one of the farthest along in terms of developing a chronic virus vaccine what they have said is that they do expect to submit data to the f.d.a. the u.s. regulator by the end of october along with their partner pfizer that means that it could potentially be approved by october or november and it's shipped out so

$750000000.00 doses per year for that bio on tech is buying a production facility in the german city of marburg from pharmaceuticals giant no vargas the drug is being developed in collaboration with pfizer. a video released by friends of kremlin critic alexina volley claims the prominent political figure was poisoned in his siberian hotel room and not the airport as was previously thought nova chalk the nerve agent used to poison the well me was the tech did on an empty water bottle at the hotel. well here in germany police of a launched raids against some of their colleagues officers suspected of sharing human also images and private online chat chat groups 29 police officers in the german state of north rhine-westphalia have been suspended 11 are now under criminal investigation images share include pictures of illegal symbols in germany like swastikas. by this grace and a slap in the face for germany's police forces that's what the interior minister in north rhine-westphalia called the discovery of czech content in which 29 police officers shared right wing extremist material. including for

will purchase a production facility in the german city of marburg for exams which will start to nobody's. severe flooding in nigeria's north west and kept the state has left several people dead and many more homeless and sparked fears for the nation's food security cabbies the country's main producer of staple crops like rice maize and millet the state's emergency agency says floodwaters have have submerged about 500000 hectares of farmland. this is d.w. news life from ballet and still to come county public schools keep our children safe from 19 as a question worrying nigerian parents as classes begin again. first so india became the country with the world's 2nd highest a coronavirus caseload after the united states with more than 5000000 confirmed cases and week of daily increases of 90000 infections are surging. the government believes the country's relatively low fatality rate is sign it has the pandemic under control there are doubts though about whether the $83000.00 reported carvey deaths convey a true picture saying goodbye to a husband and a father. mitra died in july after he wa

german biotech specialist biotech is buying a production facility in the german city of marburg from pharma giant novartis many analysts considered by intel a leading contender in the race to produce a qubit 19 vaccine the company says it's working on a vaccine using what's called messenger r.n.a. the drug is being developed in cooperation with pfizer and is currently in late stage testing production of a vaccine is scheduled to begin in the 1st half of next year at an annual capacity of 750000000 doses our financial correspondent charles who believe he has more. will be on tech is certainly one of the farthest along in terms of developing a crown of virus vaccine what they have said is that they do expect to submit data to the f.d.a. of us regulator by the end of october along with their partner pfizer that means that it could potentially be approved by october or november and it was shipped out soon after that but it's important to keep in mind with this that even if it does get approved by november it won't be widely available to most people for several more months the 1st doses f

german biotech specialist by untac is buying a production facility in the german city of marburg from pharma giant novartis many analysts consider by in fact a leading contender in the race to produce a covert 19 vaccine the company says it's working on a vaccine using what's called messenger r.n.a. the drug is being developed in cooperation with pfizer and is currently in late stage testing. production of a vaccine is scheduled to begin in the 1st half of next year at an annual capacity of 750000000 doses our financial correspondent chelsea believe he has more. will be on tech is certainly one of the farthest along in terms of developing a crown of virus vaccine what they have said is that they do expect to submit data to the f.d.a. the u.s. regulator by the end of october along with their partner pfizer that means that it could potentially be approved by october november and is shipped out soon after that but it's important to keep in mind with this that even if it does get approved by november it won't be widely available to most people of for several more months the 1st doses from